DNMT1 depletion and genotype-dependent decitabine response in HCT116 cells
Cell-based study · HCT116 DNMT1+/+ and isogenic DNMT1-deficient (DNMT1-Δexons3-5/Δexons3-5) colorectal cancer cells [1]
The DNMT1-deficient counterpart was less responsive to decitabine in the 96 h MTT assay. The deficient cells retained low DNMT1 protein; these data should not be interpreted as a complete protein-null system.
| Endpoint | Reported result | Reference |
|---|---|---|
| HCT116 cell viability after 96 h | IC50 DNMT1+/+: 0.48 µM; DNMT1-deficient: >10 µM | [1] |
| DNMT1 protein abundance | Qualitative immunoblot response Decitabine reduced DNMT1 protein after 48 h in DNMT1+/+ cells; low residual DNMT1 was detected in the deficient line. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Western blot: 0, 0.05, 0.5 and 5 µM; MTT: increasing concentrations (Figure 1c).
- Exposure duration
- 48 h for DNMT1 protein; 96 h for MTT viability.
- Method
- Cell exposure to decitabine; separate matched dose-response/protein readouts within the genotype-comparison study.
- Co-treatment
- Decitabine single-agent results; aza-T-dCyd and azacitidine are separate comparator compounds, not combinations.
- Reported limits
- Vehicle formulation is not specified in the selected methods. No Adooq SKU, lot or analytical stereochemical assay reported.
Methods and source locations
Compound reported in the paper: Decitabine; Compound label in the paper: DAC
Compound-level research evidence; does not validate A10292 or a particular Adooq lot.
Figure 1a-c; Results: Deletion or disruption of DNMT1 gene confers resistance to DNMTi; Methods: Cell lines and drugs, MTT assay, Western blotting
HCT116 cell viability after 96 h: MTT; triplicate samples, at least three independent experiments; Figure 1 caption reports mean ± SD. — Figure 1c and corresponding Results; Methods: MTT assay
DNMT1 protein abundance: DNMT1 Western blot with β-actin control; representative experiment from at least three independent experiments. — Figure 1a,b and caption; Methods: Western blotting